One of the fastest growing medical markets is treating and or replacing organs and cells that have been treated, but continues to be damaged by cancer cardiovascular disease and other medical problems.
The global network engineering market is expected to reach $ 11.5 billion by 2022. In this market, researchers and doctors are working to restore tissue damaged by some of the world’s weakest cancers and diseases.
It remains a major challenge in the market to monitor and continue to test the work of fabric and cells engineered to replace damaged ones. Purdue University researchers have discovered 3D mapping technology to monitor and track the behavior of engineered cells and tissues, and to increase the success rate of patients who have been exposed to debilitating diseases. This technology will be released in the edition of ACS Nano June 19.
I hope to help millions of people in need, said Chi Hwan Li, professor of engineering and biomedical engineering at Purdue Engineering College, who led the research team. Tissue engineering has given new hope to diseases that are difficult to treat, and the technology gives us more choices.
The Purdue team created a network scaffold with sensory lattices in a design that can be used to monitor the electrophysiological activity of cells and tissues. This technology uses information to create 3D activity tracking maps.